A phase 1 pharmacokinetic, safety, and tolerability study of paclitaxel injection concentrate for nano-dispersion (PICN) administered once a week in subjects with advanced solid malignancies in Indian population.
Phase of Trial: Phase I
Latest Information Update: 30 Aug 2016
At a glance
- Drugs Paclitaxel (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 21 Mar 2012 Additional lead trial investigator (Minish Jain) identified as reported by Clinical Trials Registry - India record.
- 20 Jan 2012 New trial record